A Technology Transfer Model from Public to Private Sector in Biopharmaceutical Industry

Describing a new model implemented by Butantan Institute a centenary Brazilian public research institute to develop a new molecule as a therapeutic agent with public and private funding. Different from the creation of a new technology-based enterprise, this model proposes to internalize the scale up process in the research institute in order to develop the trials, and then transfer all the technology of the process and the related knowledge to the private sector to begin the production. It seems a reasonable and feasible model for Brazilian biopharmaceutical companies, as most of them do not have research and activity-development background, nor cross disciplinary teams or even equipment that are crucial for the development stages of innovative pharmaceutical products. In contrast, some Brazilian public institutions, such as research institutions, have some worldwide known researchers in different fields of knowledge, and also a lot of world-class equipment. The main aim of this proposal of a new technology transfer model is to enable the production of new biopharmaceutical products, thus driving innovation in the biopharmaceutical sector.